openPR Logo
Press release

BioVex Inc.'s Talimogene Laherparepvec (Imlygic) market size expected to increase many folds by 2032, report DelveInsight

02-14-2024 07:19 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Talimogene Laherparepvec (Imlygic) market

Talimogene Laherparepvec (Imlygic) market

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Talimogene Laherparepvec (BioVex Inc.'s) providing insights into the drug market landscape and market forecast of Talimogene Laherparepvec upto 2032. The report, titled "Talimogene Laherparepvec Market Size, Forecast, and Drug Insight - 2032" is now available for review and analysis.

Are you interested in finding out the projected market size of Talimogene Laherparepvec in 2032? Click @ Talimogene Laherparepvec Market Size @ https://www.delveinsight.com/report-store/talimogene-laherparepvec-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=druginsightpr&utm_campaign=apr

The Talimogene Laherparepvec Market Report offers projected sales forecasts for Talimogene Laherparepvec for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.

BioVex Inc.'s Talimogene Laherparepvec is serving as a beacon of hope for the patients suffering from Melanoma.

Drug Summary
Talimogene laherparepvec (Imlygic), commercially known as Imlygic, is a genetically modified form of herpes simplex virus type 1 that is injected directly into tumors. Within the tumors, it undergoes replication and generates granulocyte-macrophage colony-stimulating factor (GM-CSF), an immunostimulatory protein. Imlygic induces the rupture and death of the tumor through a process called lysis. This rupture releases tumor-derived antigens, which, in conjunction with virally-derived GM-CSF, may trigger an anti-tumor immune response. While the precise mechanism is not fully understood and is under ongoing investigation, Imlygic holds the distinction of being the first FDA-approved oncolytic viral therapy based on demonstrated therapeutic benefits in a pivotal study.
The report extensively covers the details and developments related to Talimogene Laherparepvec, capturing important highlights on developmental pipeline, regulatory status and special designations of Talimogene Laherparepvec, route of administration, safety and efficacy details.

Talimogene Laherparepvec Market Assessment
This report provides a detailed market assessment of Talimogene Laherparepvec for Melanoma in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.

Talimogene Laherparepvec Clinical Assessment
The report provides the clinical trials information of Talimogene Laherparepvec for Melanoma covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related.

Do you know your drug's competitive positioning against Talimogene Laherparepvec? Talimogene Laherparepvec Drug Insights @ https://www.delveinsight.com/sample-request/talimogene-laherparepvec-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=druginsightpr&utm_campaign=apr

Talimogene Laherparepvec Competitive Landscape
The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the Talimogene Laherparepvec.

Talimogene Laherparepvec Market Size in the US
A dedicated section of the report focuses on the expected market size of Talimogene Laherparepvec for the United States. DelveInsight's analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.

What is a Talimogene Laherparepvec Prescribed for?
Talimogene laherparepvec (T-VEC), also known as Imlygic, is a form of immunotherapy designed for treating unresectable melanoma skin cancer that has metastasized to other regions of the skin, soft tissue, or lymph nodes, making it inaccessible for surgical removal.

Key Highlights of Talimogene Laherparepvec:
• The report contains forecasted sales of Talimogene Laherparepvec for indication till 2032.
• Comprehensive coverage of the late-stage emerging therapies for Melanoma.
• The report also features the qualitative and quantitative analysis with analysts as well as KOL views for Talimogene Laherparepvec in Melanoma.

Stay ahead in competition by leveraging insights on Talimogene Laherparepvec market Report: Download @ https://www.delveinsight.com/report-store/talimogene-laherparepvec-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=druginsightpr&utm_campaign=apr

Why you should buy Talimogene Laherparepvec Market Report:
• The report provides future market assessments for Talimogene Laherparepvec for Melanoma in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts' views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
• Leading Talimogene Laherparepvec for Melanoma forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the Talimogene Laherparepvec
• Discover the competitive landscape of Talimogene Laherparepvec through 7MM
• Get a Through Analysis of the Talimogene Laherparepvec Development pipeline, Safety & Efficacy of the Talimogene Laherparepvec, and ROA
• Thorough Talimogene Laherparepvec market forecast will help understand how drug is competing with other emerging Talimogene Laherparepvec
• Get analysis of the Talimogene Laherparepvec clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
• Drug Market forecasts are calculated after taking into consideration KOL viewpoints

Top Services Offered By DelveInsight:
Elevate healthcare strategies with Delveinsight Healthcare Consulting. Unlock insights, navigate challenges, and drive success in the dynamic healthcare landscape. https://www.delveinsight.com/consulting

Trending Report:
• Hiatal Hernia Market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Lhon Market: https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Vascular Dementia Market: https://www.delveinsight.com/report-store/vascular-dementia-market
• Acquired Hemophilia A Pipeline: https://www.delveinsight.com/report-store/acquired-hemophilia-a-pipeline-insight
• Acute Gout Flare Market: https://www.delveinsight.com/report-store/acute-gout-flare-market
• Adrenal Insufficiency Market: https://www.delveinsight.com/report-store/adrenal-insufficiency-market
• Alkaptonuria Market: https://www.delveinsight.com/report-store/alkaptonuria-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-idiopathic-urticaria-market
• Contusion Market: https://www.delveinsight.com/report-store/contusion-market
• Heavy Metal Poisoning Markets: https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
• Microsatellite Stable Colorectal Cancer Market: https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market
• Phosphoglucomutase Pgm 1 Deficiency Market: https://www.delveinsight.com/report-store/phosphoglucomutase-pgm-1-deficiency-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Progressive Familial Intrahepatic Cholestasis Market: https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market
• Pulmonary Hypertension Associated With Interstitial Lung Disease Market: https://www.delveinsight.com/report-store/pulmonary-hypertension-associated-with-interstitial-lung-disease-ph-ild-market
• Upper Limb Hypertonia Market: https://www.delveinsight.com/report-store/upper-limb-hypertonia-market
• Vestibular Schwannoma Market: https://www.delveinsight.com/report-store/vestibular-schwannoma-market
• Advanced Hepatocellular Carcinoma With Cpb Liver Cirrhosis Market: https://www.delveinsight.com/report-store/advanced-hepatocellular-carcinoma-with-cpb-liver-cirrhosis-market-insight
• Aids Related Kaposi's Sarcoma Market: https://www.delveinsight.com/report-store/aids-related-kaposis-sarcoma-market
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Apraxia Market: https://www.delveinsight.com/report-store/apraxia-market
• Antiphospholipid Syndrome Aps Market: https://www.delveinsight.com/report-store/antiphospholipid-syndrome-aps-market
• Hallux Valgus Market: https://www.delveinsight.com/report-store/hallux-valgus-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Kidney Transplant Rejection Market: https://www.delveinsight.com/report-store/kidney-transplant-rejection-market
• Nmibc Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• T-cell-prolymphocytic Leukemia Market: https://www.delveinsight.com/report-store/t-cell-prolymphocytic-leukemia-market
• Adult Onset Still Disease Market: https://www.delveinsight.com/report-store/adult-onset-still-disease-market
• Biliary Tract Cancer Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Triple Negative Breast Cancer Market: https://www.delveinsight.com/report-store/triple-negative-breast-cancer-tnbc-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/report-store/pemphigus-vulgaris-market
• Helicobacter Pylori Infections Market: https://www.delveinsight.com/report-store/helicobacter-pylori-h-pylori-infection-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Bronchial Spasms Market: https://www.delveinsight.com/report-store/bronchial-spasm-market
• Chronic Cutaneous Ulcer Market: https://www.delveinsight.com/report-store/chronic-cutaneous-ulcer-market
• Chronic Gout Market: https://www.delveinsight.com/report-store/chronic-gout-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Leber's Hereditary Optic Neuropathy Market: https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
• Malt Lymphoma Market: https://www.delveinsight.com/report-store/malt-lymphoma-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Radiation Toxicity Market: https://www.delveinsight.com/report-store/radiation-toxicity-market
• Rhino Conjunctivitis Market: https://www.delveinsight.com/report-store/rhino-conjunctivitis-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BioVex Inc.'s Talimogene Laherparepvec (Imlygic) market size expected to increase many folds by 2032, report DelveInsight here

News-ID: 3383696 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Market:

Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview: The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by